SCNI Scinai Immunotherapeutics Ltd.
$0.54▼ -4.07%
Healthcare
Other
Pre-market
$0.52▼ -3.51%
Oct 27, 6:42 AM ET
Volume 122.2K
Avg Volume (10D) 6.81M
Key Metrics & Fundamentals
Market Cap
$732,772
P/E Ratio
0.0
Div Yield
0.00%
52W Range
0.52 - 15.50
% vs 50 MA
-68.05%
% vs 200 MA
-88.27%
RSI-14
24.4
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.86
Free Cash Flow
-$2.58M
Gross Rev
$460,000
Gross Profit
-$1.25M
EBITDA
$4.60M
COGS
$1.71M
Operating Exp
$894,000
Operating Income
-$2.15M
EBIT
-$2.15M
Pretax Income
-$2.00M
Net Income
-$2.00M
Price & Volume History
Loading chart…
Recent News
Scinai CEO Updates Shareholders on CDMO Growth and Extended Runway Following Completed Financing
PR Newswire · Oct 20, 2026 8:35 AM ET
Scinai Immunotherapeutics Announces Closing of $4.0 Million Financing Through a Private Placement and Warrant Inducement
PR Newswire · Oct 16, 2026 8:00 AM ET
Scinai Immunotherapeutics Announces $4.0 Million Financing Through a Private Placement and Warrant Inducement
PR Newswire · Oct 14, 2026 8:00 AM ET
Scinai Expands CDMO Business with $5.1 Million Development and Clinical Manufacturing Agreement
PR Newswire · Oct 13, 2026 7:00 AM ET
Scinai Regains Compliance with Nasdaq Minimum Bid Price Requirement
PR Newswire · Sep 21, 2026 7:00 AM ET
Scinai Concludes PC111 Arrangements and Refocuses Capital on NanoAb Platform and Growing CDMO Business
PR Newswire · Sep 8, 2026 9:15 AM ET
Scinai Reports First Half 2026 Corporate Highlights and Results with Spotlight on Growing CDMO Momentum
PR Newswire · Aug 24, 2026 7:00 AM ET
Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration
PR Newswire · Aug 10, 2026 6:34 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See SCNI's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.